Asia Pacific HIV Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening {Third Generation and Fourth Generation}, Differentiation & Confirmation Test, and Monitoring Test {CD4 Tests and Viral Load Tests}), by End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • Published On : Jan 2019 |
  • Pages : 178 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Asia Pacific HIV Diagnostics Market – Insights

HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV includes testing services in health-care facilities, free-standing sites, and a wide range of community-based approaches along with HIV self-testing. Developments such as home testing represent new and major opportunities for addressing HIV among men who have sex with men (MSM). According to the UNAIDS, the Joint United Nations Program on HIV and AIDS, 2018 data, Asia Pacific recorded around 5.2 million people living with HIV in 2017.

The Asia Pacific HIV diagnostics market size was valued at US$ 301.1 million in 2017, and is expected to witness a CAGR of 12.3% over the forecast period (2018 – 2026).

Asia Pacific HIV Diagnostics Market Revenue (US$ Mn) Analysis, By Product Type, 2017

Asia Pacific HIV Diagnostics  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing Government Initiatives to Reduce HIV/AIDS Burden are Expected to Drive Asia Pacific HIV Diagnostics Market Revenue

Governments of various countries in Asia Pacific are taking initiatives to create awareness regarding HIV among people due to high prevalence of HIV/AIDS in the region. This in turn is increasing adoption of HIV diagnostic instruments and test kits. Low literacy rate coupled with unawareness regarding transmission mode on HIV, changing lifestyle, and unsafe sex are some of the factors leading to increasing number of HIV cases. In order to lower the disease incidence and increase life expectancy of infected patients, governments of various countries along with NGOs are focusing on improving HIV diagnostics and making them easily accessible to the general population.

In 2014, UNAIDS, the Joint United Nations Program on HIV and AIDS, is engaged in global efforts to end AIDS as a public health threat by 2030 and is a part of the UN Sustainable Development Goal. According to UNAIDS targets, by 2020, 90% of all people living with HIV will know HIV status and 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. Furthermore, around US$ 3.7 billion was available in 2017 for the AIDS response in Asia Pacific, according to UNAIDS.

Asia Pacific HIV Diagnostics Market Restraints

Several variants of the virus are found worldwide and some variants tend to be more prevalent in certain geographies than others. Testing kits, when not designed to accommodate this variation, can provide incorrect results. Furthermore, inadequacy of competent healthcare personnel, unreliability of test results, and poor staff attitudes are other major factors driving patients away from HIV screening. For instance, in June 2017, Health Sciences Authority (HSA), Singapore; recalled 9 lots of HIV screening test kits, after it was found that the kits could result in false negative results for some people in the early stages of HIV infection. Furthermore, lack of awareness regarding testing procedures, inaccessibility to testing sites, inconvenient testing hours, and cost of testing are also negatively impacting Asia Pacific HIV diagnostics market growth.

Asia Pacific HIV Diagnostics Market - Country Insights

Asia Pacific HIV diagnostics market revenue is expected to foresee significant growth over the forecast period. The market in India is expected to be a major driver for Asia Pacific HIV diagnostics market growth, owing to high prevalence of HIV epidemic in India, with major cases concentrated among sex workers, homosexuals, people who inject drugs, and transgenders. For instance, according to Avert, 2.1 million people were suffering from HIV in 2017 in India.

Increasing HIV testing and counselling facilities in India is driving demand for HIV-based diagnostic products. For instance, according to National AIDS Control Organization’s (NACO) 2017-2018 annual report, the number of HIV testing and counselling sites in India increased from 67 in 1997, to around 23,400 facilities in 2017. Furthermore, between April 2016 and April 2017, around 18.6 million general users accessed these services, surpassing India’s annual testing target of 14 million.

Asia Pacific HIV Diagnostics Market Share 2017 (%), By Country

  Asia Pacific HIV Diagnostics  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Asia Pacific HIV Diagnostics Market - Competitive Landscape

Key players operating in the Asia Pacific HIV diagnostics market include, Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo Diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation.

Although the most efficient test results are obtained by Enzyme-Linked Immunosorbent Assay (ELISA) test initially and later by Western blot method, HIV diagnosis can be performed by blood test, saliva test, and viral load test. The ELISA test is an enzyme-linked immunosorbent assay and uses antibodies to identify the substance. The Western blot technique is used to detect anti –HIV antibodies in the human serum sample. According to WHO, the HIV diagnosis includes free –standing sites, testing services in health care facilities, some community-based approaches and HIV self-testing (HIVST).

Market Dynamics

Increasing engagement programs by various government bodies to reduce disease burden of HIV epidemics and growing need for safe blood transfusion and donations in Asia Pacific is expected to drive the HIV diagnostic market size during the forecast period. For instance, India plans to make Pre-exposure prophylaxis (PrEP) available to men who have sex with men (MSM) and transgender women. The Indian Council of Medical Research (ICMR) indicated in November 2018 that it is planning to study the effectiveness of PrEP in high-risk groups.

However, stigma and social ostracism associated with HIV infections and diseases is expected to hinder the timely HIV diagnostics and treatment. Moreover, the fear of being tested positive, discrimination, rejection, and stigma restricts several people from conducting screening voluntarily. The fear of discord in marital relationships is yet another challenge where testing HIV positive is often seen as a case of infidelity. Therefore, these factors are expected to hamper the market growth.  

Key features of the study:

  • This report provides in-depth analysis of the Asia Pacific HIV diagnostics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Asia Pacific HIV diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The Asia Pacific HIV diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Asia Pacific HIV Diagnostics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Asia Pacific HIV Diagnostics Market, By Product Type:
    • Instruments
    • Reagents & Kits
  • Asia Pacific HIV Diagnostics Market, By Test Type:
    • Screening
      • Third Generation
      • Fourth Generation
    • Differentiation & Confirmation Test
    • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
  • Asia Pacific HIV Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Home Care Settings
    • Others
  • Asia Pacific HIV Diagnostics Market, By Country:
    • Japan
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • China
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • South Korea
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • ASEAN
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • Australia
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • India
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
    • Rest of APAC
      • By Product Type:
        • Instruments
        • Reagents & Kits         
      • By Test Type:
        • Screening
          • Third Generation
          • Fourth Generation
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck KGaA
    • Hoffmann-La Roche AG
    • Atomo Diagnostics
    • Siemens Healthineers, Inc.
    • bioLytical Laboratories Inc.
    • MedMira Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Test Type
      • Market Snippet, By End User
      • Market Snippet, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Epidemiology Analysis
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis 
  4. Asia Pacific HIV Diagnostics Market, By Product Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Reagents & Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  5. Asia Pacific HIV Diagnostics Market, By Test Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
        • Third Generation
        • Fourth Generation
    • Differentiation & Confirmation Test
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Monitoring Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
        • CD4 Tests
        • Viral Load Tests
  6. Asia Pacific HIV Diagnostics Market, By End User, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Diagnostic Laboratories
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Home Care Settings
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Others
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  7. Asia Pacific HIV Diagnostics Market, By Country, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Country, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Country, 2017 – 2026
      • Country Trends
    • Japan
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • China
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • South Korea
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • ASEAN
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • Australia
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • India
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
    • Rest of Asia Pacific
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Test Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
  8. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Atomo Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Siemens Healthineers, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • bioLytical Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • MedMira Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 22 market data tables and 14 figures on "Asia Pacific HIV Diagnostics Market” - Asia Pacific forecast to 2026”

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.